Abstract
Background
The prognosis of hepatocellular carcinoma (HCC) with portal hypertension (PH) is very poor. Splenomegaly is considered important evidence of PH. Our aim was to clarify the prognostic value of splenic volume (SV) and the effect of splenectomy on the prognosis of HCC within the Milan criteria after curative hepatectomy.
Methods
In this single-center retrospective study, we reviewed 160 patients with HCC that met the Milan criteria, including 138 who had undergone hepatectomy and 22 who had undergone hepatectomy and splenectomy between July 2004 and December 2010. SV was measured by three-dimensional computed tomography and patients allocated to three groups (high SV ≥300 mL; low <300 mL; and splenectomy) to compare post-hepatectomy survival rates.
Results
Multivariate analyses showed that SV is an independent prognostic factor for overall and disease-free survival. The overall survival rates at 5 years in the high SV, low SV, and splenectomy groups were 39, 75, and 88%, respectively. The overall survival rate in the high SV group was significantly worse than in the low SV and splenectomy groups (P < 0.001). There was no significant difference between the low SV and splenectomy groups (P = 0.831).
Conclusions
High SV is an independent predictor of post-hepatectomy HCC recurrence and overall survival. There is no significant difference in prognosis between low SV and splenectomy groups, even though the latter had high SV. Combined splenectomy with hepatectomy for HCC and PH may improve prognosis and be an appropriate alternative when liver transplantation cannot be performed.
Similar content being viewed by others
Abbreviations
- HCC:
-
Hepatocellular carcinoma
- PH:
-
Portal hypertension
- SV:
-
Splenic volume
- ICGR15 :
-
Indocyanine green dye retention rate at 15 min
- CT:
-
Computed tomography
- AFP:
-
α-Fetoprotein
- DCP:
-
Des-gamma carboxyprothrombin
- mVp:
-
Micro-portal vein tumor invasion
- IM:
-
Intrahepatic metastasis
- CI:
-
Confidence intervals
References
Kiyosawa K, Umemura T, Ichijo T et al (2004) Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127:S17–S26
Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543
Yamashita Y, Taketomi A, Itoh S et al (2007) Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 205:19–26
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430
Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699
Kawanaka H, Akahoshi T, Kinjo N et al (2014) Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension. Br J Surg 101:1585–1593
Anegawa G, Kawanaka H, Uehara H et al (2009) Effect of laparoscopic splenectomy on portal hypertensive gastropathy in cirrhotic patients with portal hypertension. J Gastroenterol Hepatol 24:1554–1558
Li WX, Zhao XT, Chai WM et al (2010) Hepatitis B virus-induced liver fibrosis and cirrhosis: the value of liver and spleen volumetry with multi-detector spiral computed tomography. J Dig Dis 11:215–223
Liu P, Li P, He W et al (2009) Liver and spleen volume variations in patients with hepatic fibrosis. World J Gastroenterol 15:3298–3302
Iranmanesh P, Vazquez O, Terraz S et al (2014) Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma. J Hepatol 60:969–974
Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338
Ikegami T, Shimada M, Imura S (2008) Recent role of splenectomy in chronic hepatic disorders. Hepatol Res 38:1159–1171
Kawanaka H, Akahoshi T, Kinjo N et al (2009) Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism. J Hepatobiliary Pancreat Surg 16:749–757
Shimada M, Hashizume M, Shirabe K et al (2000) A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc 14:127–130
Chen XP, Wu ZD, Huang ZY et al (2005) Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg 92:334–339
Zhang XY, Li C, Wen TF et al (2015) Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: a case-control study. World J Gastroenterol 21:2358–2366
Takeishi K, Shirabe K, Muto J et al (2011) Clinicopathological features and outcomes of young patients with hepatocellular carcinoma after hepatectomy. World J Surg 35:1063–1071. doi:10.1007/s00268-011-1017-7
Tsujita E, Yamashita Y, Takeishi K et al (2012) Poor prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma in the modern era. Am Surg 78:419–425
Kanematsu T, Furuta T, Takenaka K et al (1989) A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 10:98–102
Shimada M, Takenaka K, Gion T et al (1996) Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 111:720–726
Liver Cancer Study Group of Japan (2003) General rules for the clinical and pathological study of primary liver cancer, 2nd English edn. Kanehara, Tokyo
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Eguchi S, Kanematsu T, Arii S et al (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143:469–475
Ushitora Y, Tashiro H, Takahashi S et al (2011) Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg 28:9–14
Kinjo N, Nagao Y, Akahoshi T et al (2013) Hepatic vein waveform and splenomegaly predict improvement of prothrombin time after splenectomy in hepatitis C virus-related cirrhotic patients. Hepatol Res 43:933–941
Takeishi K, Maeda T, Tsujita E et al (2015) Predictors of intrahepatic multiple recurrences after curative hepatectomy for hepatocellular carcinoma. Anticancer Res 35:3061–3066
Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207
Poon RT, Fan ST, Ng IO et al (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500–507
Portolani N, Coniglio A, Ghidoni S et al (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243:229–235
Murata K, Ito K, Yoneda K et al (2008) Splenectomy improves liver function in patients with liver cirrhosis. Hepatogastroenterology 55:1407–1411
Ripoll C, Groszmann RJ, Garcia-Tsao G et al (2009) Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 50:923–928
Ganne-Carrie N, Chastang C, Chapel F et al (1996) Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology 23:1112–1118
Hashimoto N, Shimoda S, Kawanaka H et al (2011) Modulation of CD4(+) T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis. Clin Exp Immunol 165:243–250
Ninomiya M, Shirabe K, Facciuto ME et al (2015) Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma. J Am Coll Surg 220(297–304):e293
Faitot F, Allard MA, Pittau G et al (2015) Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation. Hepatology 62:179–187
Taketomi A, Kitagawa D, Itoh S et al (2007) Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg 204:580–587
European Association for the Study of the Liver (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943
Acknowledgements
This work was supported by a grant from Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (Grant Number 25670583) and Kaibara Morikazu Medical Science Promotion Foundation. The authors thank Professor Takeharu Yamanaka, Yokohama City University, for statistical advice and Dr.Trish Reynolds, MBBS, FRACP, from Edanz Group for editing a draft of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Takeishi, K., Kawanaka, H., Itoh, S. et al. Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy. World J Surg 42, 1120–1128 (2018). https://doi.org/10.1007/s00268-017-4232-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-017-4232-z